Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001190416 | SCV001357897 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-10-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001516078 | SCV001724292 | benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2023-12-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001597252 | SCV001830529 | likely benign | not provided | 2021-05-28 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002276657 | SCV002566512 | likely benign | Connective tissue disorder | 2020-05-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001190416 | SCV002718248 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-05-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003235488 | SCV003934304 | likely benign | not specified | 2023-05-15 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004010433 | SCV004814929 | benign | Marfan syndrome | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004538423 | SCV004715704 | likely benign | FBN1-related disorder | 2022-06-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |